Evidence map›Paper›PMID 38380656›Full record

ReviewChemical Society reviews2024

Plasmonic silver and gold nanoparticles: shape- and structure-modulated plasmonic functionality for point-of-caring sensing, bio-imaging and medical therapy.

Yingjie Hang, Anyang Wang, Nianqiang Wu

Abstract readReview
In one paragraph

Review in Chemical Society reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. A {Αg Plasmonic Film}/{FeL@SiOLangmuir : the ACS journal of surfaces and colloids · 2026
    Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yingjie HangDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003-9303, USA. nianqiangwu@umass.edu.
Anyang WangDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003-9303, USA. nianqiangwu@umass.edu.
Nianqiang WuDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003-9303, USA. nianqiangwu@umass.edu.ORCID http://orcid.org/0000-0002-8888-2444

Funding

TrainingU54EB007958 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Yukari C Manabe · 2007 to 2026
$34.6M
Role of Tspan5 in MHC I antigen presentation and cancer immune evasionR01AI114495 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROCK, KENNETH L · 2016 to 2025
$4.6M
NIAID NIH HHS R01 AI114495NIBIB NIH HHS U54 EB007958
6 · The paper itself

Abstract

Silver and gold nanoparticles have found extensive biomedical applications due to their strong localized surface plasmon resonance (LSPR) and intriguing plasmonic properties. This review article focuses on the correlation among particle geometry, plasmon properties and biomedical applications. It discusses how particle shape and size are tailored

Indexed as

GoldMetal NanoparticlesSilverSpectrum Analysis, RamanSurface Plasmon ResonanceGoldSilver

Identifiers

PMID38380656
PMCPMC11849058

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.